Michele Prisciandaro

2.3k total citations
49 papers, 761 citations indexed

About

Michele Prisciandaro is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Michele Prisciandaro has authored 49 papers receiving a total of 761 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Oncology, 23 papers in Pulmonary and Respiratory Medicine and 15 papers in Cancer Research. Recurrent topics in Michele Prisciandaro's work include Colorectal Cancer Treatments and Studies (11 papers), Cancer Genomics and Diagnostics (11 papers) and Genetic factors in colorectal cancer (9 papers). Michele Prisciandaro is often cited by papers focused on Colorectal Cancer Treatments and Studies (11 papers), Cancer Genomics and Diagnostics (11 papers) and Genetic factors in colorectal cancer (9 papers). Michele Prisciandaro collaborates with scholars based in Italy, United States and Germany. Michele Prisciandaro's co-authors include Filippo de Braud, Giovanni Randon, Alice Indini, Carolina Cimminiello, Lorenza Di Guardo, Michele Del Vecchio, Alessia Mennitto, Claudio Vernieri, Monica Milano and Gabriella Mariani and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Michele Prisciandaro

45 papers receiving 750 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michele Prisciandaro Italy 15 566 270 157 146 119 49 761
Marie Alt France 11 543 1.0× 256 0.9× 123 0.8× 160 1.1× 119 1.0× 20 748
Albiruni Abdul Razak Canada 12 425 0.8× 267 1.0× 138 0.9× 98 0.7× 132 1.1× 37 726
Giovanni Randon Italy 16 673 1.2× 361 1.3× 140 0.9× 141 1.0× 183 1.5× 51 915
Sara Elena Rebuzzi Italy 15 394 0.7× 331 1.2× 117 0.7× 107 0.7× 79 0.7× 67 643
Navid Hafez United States 12 530 0.9× 126 0.5× 229 1.5× 117 0.8× 98 0.8× 34 723
Xinmin Yu China 18 746 1.3× 704 2.6× 193 1.2× 217 1.5× 112 0.9× 48 1.1k
Sabrina Rossi Italy 19 611 1.1× 403 1.5× 155 1.0× 181 1.2× 76 0.6× 55 899
Alfredo Mellano Italy 12 641 1.1× 207 0.8× 180 1.1× 195 1.3× 324 2.7× 24 917
Jiemin Zhao China 12 612 1.1× 187 0.7× 151 1.0× 137 0.9× 115 1.0× 28 856
Bin Meng China 18 334 0.6× 186 0.7× 245 1.6× 141 1.0× 152 1.3× 62 814

Countries citing papers authored by Michele Prisciandaro

Since Specialization
Citations

This map shows the geographic impact of Michele Prisciandaro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michele Prisciandaro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michele Prisciandaro more than expected).

Fields of papers citing papers by Michele Prisciandaro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michele Prisciandaro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michele Prisciandaro. The network helps show where Michele Prisciandaro may publish in the future.

Co-authorship network of co-authors of Michele Prisciandaro

This figure shows the co-authorship network connecting the top 25 collaborators of Michele Prisciandaro. A scholar is included among the top collaborators of Michele Prisciandaro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michele Prisciandaro. Michele Prisciandaro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pinto, Carmine, Sara Lonardi, Evaristo Maiello, et al.. (2025). Trifluridine/tipiracil regimen in combination with bevacizumab for metastatic colorectal cancer in the third line: an expert opinion. Frontiers in Oncology. 14. 1502185–1502185.
2.
Prisciandaro, Michele, Javier Ros, Mario Mandalà, et al.. (2025). 723O Post-surgical liquid biopsy-guided treatment of stage III and high-risk stage II colon cancer patients: Final results of the PEGASUS trial. Annals of Oncology. 36. S474–S474. 1 indexed citations
3.
Sorrentino, Luca, Luigi Battaglia, Giovanna Sabella, et al.. (2024). Outcomes of chemotherapy/chemoradiation vs. R2 surgical debulking vs. palliative care in nonresectable locally recurrent rectal cancer. Tumori Journal. 110(5). 360–365.
4.
5.
Raimondi, Alessandra, Federico Nichetti, Arndt Stahler, et al.. (2023). Optimal maintenance strategy following FOLFOX plus anti-EGFR induction therapy in patients with RAS wild type metastatic colorectal cancer: An individual patient data pooled analysis of randomised clinical trials. European Journal of Cancer. 190. 112945–112945. 7 indexed citations
6.
Moretto, Roberto, Marco Maria Germani, Mirella Giordano, et al.. (2023). Trop-2 and Nectin-4 immunohistochemical expression in metastatic colorectal cancer: searching for the right population for drugs’ development. British Journal of Cancer. 128(7). 1391–1399. 14 indexed citations
7.
Fucà, Giovanni, Alessandra Raimondi, Michele Prisciandaro, et al.. (2022). Reinduction of an Anti-EGFR-based First-line Regimen in Patients with RAS Wild-type Metastatic Colorectal Cancer Enrolled in the Valentino Study. The Oncologist. 27(1). e29–e36. 5 indexed citations
8.
Prete, Alessandra Anna, Paolo Manca, Federica Morano, et al.. (2022). Extensive molecular profiling of squamous cell anal carcinoma in a phase 2 trial population: Translational analyses of the “CARACAS” study.. Journal of Clinical Oncology. 40(4_suppl). 5–5. 1 indexed citations
9.
Prisciandaro, Michele, Maria Antista, Alessandra Raimondi, et al.. (2022). Biomarker Landscape in Neuroendocrine Tumors With High-Grade Features: Current Knowledge and Future Perspective. Frontiers in Oncology. 12. 780716–780716. 6 indexed citations
10.
Pusceddu, Sara, Claudio Vernieri, Natalie Prinzi, et al.. (2020). The potential role of metformin in the treatment of patients with pancreatic neuroendocrine tumors: a review of preclinical to clinical evidence. Therapeutic Advances in Gastroenterology. 13. 3974116135–3974116135. 9 indexed citations
11.
Pusceddu, Sara, Roberta Rossi, Martina Torchio, et al.. (2020). Differential Diagnosis and Management of Diarrhea in Patients with Neuroendocrine Tumors. Journal of Clinical Medicine. 9(8). 2468–2468. 12 indexed citations
12.
Prinzi, Natalie, Roberta Rossi, Claudia Proto, et al.. (2020). Recent Advances in the Management of Typical and Atypical Lung Carcinoids. Clinical Lung Cancer. 22(3). 161–169. 15 indexed citations
13.
14.
Raimondi, Alessandra, Raffaele Ratta, Elena Verzoni, et al.. (2019). Cabozantinib in Renal Cell Carcinoma With Brain Metastases: Safety and Efficacy in a Real-World Population. Clinical Genitourinary Cancer. 17(4). 291–298. 24 indexed citations
15.
Vernieri, Claudio, Michele Prisciandaro, Monica Milano, et al.. (2018). Single-Agent Gemcitabine vs. Carboplatin-Gemcitabine in Advanced Breast Cancer: A Retrospective Comparison of Efficacy and Safety Profiles. Clinical Breast Cancer. 19(2). e306–e318. 11 indexed citations
16.
Indini, Alice, Lorenza Di Guardo, Carolina Cimminiello, et al.. (2018). Immune-related adverse events correlate with improved survival in patients undergoing anti-PD1 immunotherapy for metastatic melanoma. Journal of Cancer Research and Clinical Oncology. 145(2). 511–521. 159 indexed citations
17.
Cavalieri, Stefano, Federico Nichetti, Daniele Morelli, et al.. (2017). Pro-GRP in small cell lung cancer. Annals of Oncology. 28. ii18–ii18. 1 indexed citations
18.
Grassi, Paolo, Elena Verzoni, Raffaele Ratta, et al.. (2017). Does Dose Modification Affect Efficacy of First-Line Pazopanib in Metastatic Renal Cell Carcinoma?. Drugs in R&D. 17(3). 461–467. 7 indexed citations
19.
20.
Cavalieri, Stefano, Alessandra Raimondi, Daniele Morelli, et al.. (2016). Pro-gastrin releasing peptide (pro-GRP) in small cell lung cancer staging. Annals of Oncology. 27. iv13–iv13. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marie Alt Breakdown of academic impact, for papers by Albiruni Abdul Razak Breakdown of academic impact, for papers by Giovanni Randon Breakdown of academic impact, for papers by Sara Elena Rebuzzi Breakdown of academic impact, for papers by Navid Hafez Breakdown of academic impact, for papers by Xinmin Yu Breakdown of academic impact, for papers by Sabrina Rossi Breakdown of academic impact, for papers by Alfredo Mellano Breakdown of academic impact, for papers by Jiemin Zhao Breakdown of academic impact, for papers by Bin Meng
Rankless by CCL
2026